DIRUI迪瑞品牌怎么样 申请店铺

更新时间:2024-10-28
DIRUI迪瑞是哪个国家的品牌?「DIRUI迪瑞」是 迪瑞医疗科技股份有限公司 旗下著名品牌。该品牌发源于吉林,由创始人宋洁在1994-12-26期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。
DIRUI迪瑞怎么样

迪瑞医疗正在成为全球领先的医学检验实验室整体解决方案服务商。

长春迪瑞医疗科技股份有限公司位于长春市高新技术产业开发园区,属高新技术企业。公司先后被评为“国家火炬计划重点高新技术企业”、“国家标准化良好行为AAA级企业”、“吉林省企业技术中心”,多次承担“国家级火炬计划项目”、“国家级、省级中小企业创新基金项目”,承担多项省、市级重大科技攻关项目,多项产品被评为“国家重点新产品”,是国家2011年“863计划”重大课题(CS-9200全自动生化分析检测流水线及配套试剂、质控品研制)的牵头承担单位。“迪瑞”商标于2012年被国家工商行政管理总局商标局认定为“驰名商标”。

自1992年成立以来,公司始终致力于高品质医疗检验产品(医疗仪器、诊断试剂、免疫试剂)的研发、生产及销售。产品荣获多项国家发明专利。相关产品已通过了欧盟的CE认证和美国的FDA认证,质量管理体系通过了ISO9001、ISO13485国际质量体系认证。目前公司产品覆盖国内各省并出口到100多个国家和地区。

公司主要产品有:CS系列全自动生化分析仪、BF系列全自动血细胞分析仪、FUS系列全自动尿有形成分分析仪、多系列全自动尿液分析仪、FB系列全自动便潜血分析仪及上述仪器配套的相关试剂试纸。其中,CS-6400型和CS-800型全自动生化分析仪、FUS系列全自动尿有形成分分析仪、FB系列全自动便潜血分析仪、试纸抗维生素C干扰及液体尿液分析质控液等相关产品,技术指标均达到国际同类产品先进水平。

迪瑞奉行:立足医学检验领域,科学创新、严谨安全、诚实守信的理念,为客户提供优质的产品和服务。

Dirui medical is becoming the world's leading provider of overall solutions for medical laboratory. Changchun Dirui Medical Technology Co., Ltd. is located in Changchun high tech Industrial Development Park, which is a high-tech enterprise. The company has been rated as "key high-tech enterprise of national Torch Plan", "AAA level enterprise of national standardization good behavior", "enterprise technology center of Jilin Province", has undertaken "national torch plan project", "national and provincial innovation fund project of small and medium-sized enterprises", has undertaken a number of major scientific and technological research projects at provincial and municipal levels, and a number of products have been rated as "national key" New products "is the leading undertaking unit of the national" 863 Plan "major project in 2011 (cs-9200 automatic biochemical analysis and detection line and development of supporting reagents and quality control products). "Dirui" trademark was recognized as "well-known trademark" by the Trademark Office of the State Administration for Industry and Commerce in 2012. Since its establishment in 1992, the company has been committed to the R & D, production and sales of high-quality medical inspection products (medical instruments, diagnostic reagents, immune reagents). The product has won many national invention patents. Relevant products have passed CE certification of EU and FDA certification of USA, and quality management system has passed ISO9001 and ISO13485 international quality system certification. At present, the company's products cover domestic provinces and export to more than 100 countries and regions. The company's main products are: CS series of automatic biochemical analyzer, BF series of automatic blood cell analyzer, Fus series of automatic urine sediment analyzer, multi series of automatic urine analyzer, FB series of automatic fecal occult blood analyzer and related reagent test paper matched with the above instruments. Among them, cs-6400 and cs-800 automatic biochemical analyzers, Fus series automatic urine sediment analyzers, FB series automatic fecal occult blood analyzers, test paper anti vitamin C interference and liquid urine analysis quality control solution and other related products have reached the international advanced level of similar products. Dirui pursues: Based on the field of medical testing, scientific innovation, rigorous safety, honest and trustworthy concept, to provide customers with high-quality products and services.

本文链接: https://brand.waitui.com/b70bf05d7.html 联系电话:043*****0406 立即查看

千城特选小程序码

7×24h 快讯

ST板块延续强势,*ST合泰等近20股涨停

36氪获悉,截至发稿,ST板块延续强势,*ST合泰、ST东时、ST墨龙、*ST工智、*ST中迪等近20股涨停,*ST开元涨超10%。

34分钟前

光伏板块高开低走,大全能源跌超10%

36氪获悉,截至发稿,光伏板块高开低走,大全能源跌超10%,天合光能、金刚光伏、意华股份、福斯特、中信博等多股跌超5%。

34分钟前

美国麦当劳称牛肉饼非大肠杆菌污染源,将恢复下架产品

当地时间10月27日,美国麦当劳表示,经检测,汉堡中的牛肉饼不是大肠杆菌的污染源,麦当劳将于下周恢复销售此前因涉及大肠杆菌污染而暂时下架的汉堡产品,但恢复销售的汉堡将不含目前被认为是污染源的生洋葱片。(央视新闻)

34分钟前

半导体芯片股震荡走低,锴威特跌近10%

36氪获悉,截至发稿,半导体芯片股震荡走低,锴威特跌近10%,必易微跌逾7%,富乐德、台基股份、朗科科技、圣邦股份、晶华微、国民技术等跟跌。

34分钟前

辅助生殖进医保提速扩围:10月份已有多个省份公布最新进展,辅助生殖需求有望释放

10月份以来,“扩大辅助生殖技术服务资源”成为各地重要抓手。截至10月28日,本月已有广东、湖南、山西、云南、宁夏、四川、重庆等省级行政区公布辅助生殖纳入医保最新进展。其中,10月1日起,广东、湖南、山西正式将“取卵术”等相关辅助生殖类医疗服务项目统一纳入医保范围;10月15日起,宁夏将包括“取卵术”在内的10个辅助生殖类医疗服务项目和3个加收项目纳入基本医疗保险支付范围;11月份起,四川13项辅助生殖类医疗服务项目将正式纳入医保;而重庆明年1月1日起13项辅助生殖项目将纳入医保。有机构认为,随着多个省份和直辖市跟进,预示着辅助生殖需求有望快速释放,产业链发展有望提速。(证券时报)

34分钟前

本页详细列出关于DIRUI迪瑞的品牌信息,含品牌所属公司介绍,DIRUI迪瑞所处行业的品牌地位及优势。
咨询